Search research articles
Contact Us
Filters
Showing results (171-180 of 198) with videos related to
Page
of 20
Sort By:
The Journal of Clinical Investigation
|
January 10, 2002
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome
Joanna Groom, Susan L Kalled, Anne H Cutler, et al.
Nature Chemical Biology
|
December 24, 2005
C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L
Sylvie Fournel, Sébastien Wieckowski, Weimin Sun, et al.
Blood
|
October 19, 2007
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen, Teresa G Cachero, Aubry Tardivel, et al.
The Journal of Biological Chemistry
|
May 9, 2015
Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties
Sonia Schuepbach-Mallepell, Dolon Das, Laure Willen, et al.
The Journal of Cell Biology
|
July 9, 2008
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha
James E Vince, Diep Chau, Bernard Callus, et al.
Journal of Neuroinflammation
|
October 1, 2017
α<sub>V</sub>β<sub>3</sub> Integrin regulates astrocyte reactivity
Raúl Lagos-Cabré, Alvaro Alvarez, Milene Kong, et al.
The Journal of Experimental Medicine
|
April 16, 2008
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
Bhanu P Pappu, Anna Borodovsky, Timothy S Zheng, et al.
Cell Reports
|
March 30, 2022
Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells
Cristian R Smulski, Luyao Zhang, Malte Burek, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 4, 2018
Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis
Hsin-Ying Huang, Ana Rivas-Caicedo, François Renevey, et al.
Mabs
|
June 24, 2011
Development of an Fn14 agonistic antibody as an anti-tumor agent
Jennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 198) with videos related to
Sort By:
Page
of 20
The Journal of Clinical Investigation
|
January 10, 2002
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome
Joanna Groom, Susan L Kalled, Anne H Cutler, et al.
Nature Chemical Biology
|
December 24, 2005
C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L
Sylvie Fournel, Sébastien Wieckowski, Weimin Sun, et al.
Blood
|
October 19, 2007
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen, Teresa G Cachero, Aubry Tardivel, et al.
The Journal of Biological Chemistry
|
May 9, 2015
Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties
Sonia Schuepbach-Mallepell, Dolon Das, Laure Willen, et al.
The Journal of Cell Biology
|
July 9, 2008
TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha
James E Vince, Diep Chau, Bernard Callus, et al.
Journal of Neuroinflammation
|
October 1, 2017
α<sub>V</sub>β<sub>3</sub> Integrin regulates astrocyte reactivity
Raúl Lagos-Cabré, Alvaro Alvarez, Milene Kong, et al.
The Journal of Experimental Medicine
|
April 16, 2008
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
Bhanu P Pappu, Anna Borodovsky, Timothy S Zheng, et al.
Cell Reports
|
March 30, 2022
Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells
Cristian R Smulski, Luyao Zhang, Malte Burek, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 4, 2018
Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis
Hsin-Ying Huang, Ana Rivas-Caicedo, François Renevey, et al.
Mabs
|
June 24, 2011
Development of an Fn14 agonistic antibody as an anti-tumor agent
Jennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, et al.
Page
of 20